BioSpace News Archive

Elekta announced that several cancer centers are the early adopters of the company’s first release in the MOSAIQ® 3* series.

Real Time Medical Systems (Real Time), the leading interventional analytics solution in healthcare, joins the THA Center for Innovative Solutions (TCIS) as its newest Strategic Partner.

Solano Hematology Oncology and Deep Lens today announced a strategic collaboration designed to more effectively identify, screen and match patients to precision-based clinical oncology trials using VIPER™, Deep Lens’ artificial intelligence-based screening and enrollment platform

Partnership between Shields Health Solutions and Sentara Healthcare brings patients more support services, increased number of specialty drugs and expanded insurance coverage

In tandem with its research and development partner, Lobo Genetics Inc. (“Lobo”), HaluGen has successfully developed a turn-key operation to build, order, ship, process and deliver its Psychedelics Genetic Test.

New centers will open in Southern California to support an urgent need for plasma donations used to develop therapies for people with a variety of rare diseases

The National Association of Chronic Disease Directors, with funding from the Centers for Disease Control and Prevention, and in partnership with CBS television, has launched a nationally syndicated public service announcement series and a companion, bilingual website, yourhealthbeyondcovid.org, to help Americans manage chronic diseases safely during the COVID-19 pandemic.

In the latest (free) report from Reuters Events’ Healthcare global healthcare leaders provide insights into forces to re-imagine, re-create, and re-define the entire system in a way that improves patient outcomes and experiences.

- The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, is announcing today that the first patient has been dosed and imaged in a Phase 3 trial for [ 18 F]PSMA-1007. This diagnostic imaging product is a positron-emitting tomography

ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Expanded Use of Cabenuva (cabotegravir, rilpivirine) as an HIV Treatment for Use Every 2-Months